Request Deal Involvement

Psyence Biomed went public via a SPAC merger with Newcourt Acquisition in a $50m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

McDermott Will & Emery

legal advisors

McDermott Will & Emery

Cantor Fitzgerald

financial advisors

Cantor Fitzgerald

Bayline Capital Partners

financial advisors

Bayline Capital Partners

WeirFoulds

legal advisors

WeirFoulds

Morgan Lewis & Bockius

legal advisors

Morgan Lewis & Bockius

Ellenoff Grossman & Schole

legal advisors

Ellenoff Grossman & Schole

Maxim Partners

financial advisors

Maxim Partners

or

Principals

PSYENCE BIOMEDICAL

target

PSYENCE BIOMEDICAL

NEWCOURT ACQUISITION

bidder

NEWCOURT ACQUISITION

PSYENCE GROUP

vendor

PSYENCE GROUP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite